colorectal cancer

8 Major Biopharma Events Coming Later in 2016 and in 2017
24/7 Wall St
Tue, 03/29/16 - 10:33 pm
Vertex Pharmaceuticals
VX-661
cystic fibrosis
Incyte
ruxolitinib
colorectal cancer
breast cancer
Ultragenyx
KRN23
osteomalacia
GW Pharma
Epidiolex
Puma Biotechnology
neratinib
Celator Pharmaceuticals
Vyxeos
Biocryst
OPuS-2
BCX7353
HAE
Galena Biopharma
NeuVax
trastuzumab
Merck Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration for KEYTRUDA® (pembrolizumab) in Advanced Colorectal Cancer
Yahoo
Mon, 11/2/15 - 10:04 am
Merck
Keytruda
colorectal cancer
Otsuka wins early FDA approval for a colorectal cancer combo drug
Fierce Biotech
Tue, 09/22/15 - 01:55 pm
Otsuka
colorectal cancer
FDA
TAS-102
Amgen's cancer drug meets main goal in a late-stage study
Yahoo/Reuters
Thu, 06/18/15 - 06:13 pm
Amgen
Vectibix
colorectal cancer
Amgen Announces Collaboration With Roche On Cancer Immunotherapy Study With Investigational Medicines Talimogene Laherparepvec And Atezolizumab
Yahoo
Tue, 06/2/15 - 09:15 am
Amgen
Roche
triple negative breast cancer
Talimogene Laherparepvec
atezolizumab
colorectal cancer
Good news for Lilly: Cyramza nabs yet another FDA approval
BioPharma Dive
Tue, 04/28/15 - 09:06 pm
Eli Lilly
Cyramza
FDA
colorectal cancer
Patients With Advanced Breast, Lung, Esophageal, and Colorectal Cancers Respond to Immunomedics' Novel Antibody-Directed Chemotherapy After Failing Multiple Prior Standard Treatments
Yahoo
Mon, 04/20/15 - 05:15 pm
Immunomedics
chemotherapy
breast cancer
lung cancer
esophageal cancer
colorectal cancer
sacituzumab govitecan
Will This EU Approval Move the Needle for Amgen?
Investopedia
Tue, 04/7/15 - 11:20 am
Amgen
Europe
Vectibix
colorectal cancer
Chi-Med's fruquintinib meets colorectal cancer PhII primary endpoint
Fierce Biotech
Tue, 03/31/15 - 04:07 pm
Chi-Med
fruquintinib
colorectal cancer
Colorectal Cancer Treatment Market Value to Hit $9.4B by 2020
Drug Discovery and Development
Fri, 01/23/15 - 08:22 am
colorectal cancer
Avastin
Cyramza
nintedanib
FDA Approves Sanofi SA's and Regeneron Pharmaceuticals Inc's Zaltrap for Metastatic Colorectal Cancer
Reuters
Fri, 06/6/14 - 10:08 am
FDA
Sanofi
Regneron
Zaltrap
colorectal cancer
Amgen Highlights Phase 2 Results Of Vectibix Versus bevacizumab In Combination With FOLFOX In Patients With Wild-Type RAS (KRAS And NRAS) Metastatic Colorectal Cancer
Yahoo/PR NewsWire
Sat, 05/31/14 - 10:07 am
Amgen
bevacizumab
colon cancer
colorectal cancer
Vectibix
PhIII flop for top Boston cancer stem cell program batters Dainippon Sumitomo
Fierce Biotech
Tue, 05/27/14 - 10:06 am
stem cells
Dainippon Sumitomo
Boston Biomedical
BB1608
colorectal cancer
Bristol-Myers, Incyte enter collaboration agreement for nivolumab, INCB24360
The Fly on the Wall
Tue, 05/27/14 - 09:14 am
Bristol-Myers Squibb
Incyte
nivolumab
melanoma
non-small cell lung cancer
colorectal cancer
ovarian cancer
INCB24360
Immunomedics reports results from three IMMU-130 phase I trials
Yahoo/Fly on the Wall
Mon, 04/7/14 - 12:59 pm
Immunomedics
IMMU-130
colorectal cancer
Final NICE guidance rejects Sanofi's Zaltrap in colorectal cancer
First Word Pharma
Tue, 03/25/14 - 08:06 am
NICE
Sanofi
colorectal cancer
Zaltrap
FDA says Exact Sciences colorectal cancer screening tool study met objectives
Yahoo/Fly on the Wall
Mon, 03/24/14 - 09:58 am
FDA
colorectal cancer
EXACT Sciences
Cologuard
Bayer Gets German Panel Request for Data on Cancer Drug Stivarga
Bloomberg
Thu, 03/20/14 - 05:23 pm
Bayer
Stivarga
Germany
colorectal cancer
Germany's Merck sees long-term growth in cancer drug Erbitux
Yahoo/Reuters
Fri, 10/4/13 - 10:27 am
Erbitux
Merck KGaA
Avastin
colorectal cancer
Phase 3 Trial Comparing Vectibix® (Panitumumab) to Erbitux® (Cetuximab) Meets Primary Endpoint Of Non-Inferiority Of Overall Survival
Yahoo/PR NewsWire
Sat, 09/28/13 - 11:56 am
Vectibix
colorectal cancer
Amgen

Pages